Vox Markets Logo
9th May 2024
06:00

AIM - Cancellation - Advanced Oncotherapy Plc

3rd May 2024
07:54

Advanced Oncotherapy - Further update on financing discussions

2nd April 2024
14:50

Advanced Oncotherapy - Further update on financing discussions

29th February 2024
17:19

Advanced Oncotherapy - Further update on financing discussions

1st February 2024
07:00

Advanced Oncotherapy - Further update on financing discussions

9th January 2024
09:00

Advanced Oncotherapy - Update on Financing Discussions

23rd October 2023
06:00

Advanced Oncotherapy - Update on Financing and Current Financial Position

29th September 2023
15:04

Advanced Oncotherapy - Update on Financial Results

17th July 2023
06:00

Advanced Oncotherapy - Recapitalisation and funding plan, update on FSP

30th June 2023
16:00

Advanced Oncotherapy - Total Voting Rights

30th June 2023
06:30

AIM - Suspension - Advanced Oncotherapy PLC

30th June 2023
06:15

Advanced Oncotherapy - Update on financing, suspension of trading on AIM

29th June 2023
12:35

Advanced Oncotherapy - Holding(s) in Company

26th June 2023
09:57

Advanced Oncotherapy - Partial conversion of Convertible Notes

23rd June 2023
10:05

Advanced Oncotherapy - Holding(s) in Company

20th June 2023
16:28

Advanced Oncotherapy - Holding(s) in Company

19th June 2023
16:56

Advanced Oncotherapy - Partial conversion of Convertible Notes

16th June 2023
17:23

Advanced Oncotherapy - Issue of warrants

31st May 2023
16:57

Advanced Oncotherapy - Update on financing and convertible notes

Advanced Oncotherapy Plc (AVO.L) Share Price & News


Bid
-
-
-
Ask
  • High
    -
  • OPEN
    -
  • VOL
    -
  • MKT CAP
    -M
  • LOW
    -
  • CLOSE
    -
  • SHARES IN ISSUE
    542.57M

Advanced Oncotherapy Plc Company Profile

Advanced Oncotherapy is a specialist developer and provider of a breakthrough proton therapy system, the LIGHT system, which is the result of 25 years of work at CERN and ADAM.

Our focus is on developing and supplying technologies to maximise the destructive effect of radiation on tumours whilst minimising damage to the patient's healthy tissues.

Watchlist